RVV Profile
- Sector: Health Technology
- Industry: Pharmaceuticals: Major
Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It offers the Relicann, a proprietary hemp-based cannabidiol chewing gum for the health and wellness. Its novel cannabinoid delivery technology targets diseases and disorders such as pain, inflammation, and wound care. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada.
[bbp-topic-index] [bbp-topic-form]Recent News
Revive Therapeutics Announces IRB Approval of US Expanded Access Treatment Program (Compassionate Use) for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics …
Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics …
Revive Therapeutics Advancing Drug Delivery Technology for Psychedelics
“…we see great promise in delivering psychedelic-based medicines to treat various diseases and disorders…” Developed Prototypes of Orally Dissolvable Thin Film For Psilocybin TORONTO, Aug. …
Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19
— Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical …
- Namaste Technologies Provides Corporate Update
- Halo and Green Matter Purchase Bar X Ranch to Establish the Largest Cannabis Grow in the Northern California and Southern Oregon
- Red Light Holland Reaches Distribution Agreement for iMicrodose Packs Plus Agrees to Build out an iMicrodose Media Information Centre (iMIC) with Super Smart’s Location in Tiel, The Netherlands
- Acreage Announces Opening of Nature’s Care Dispensary in Chicago’s West Loop
- Canada’s First Filtered Joint Ships to Recreational Cannabis Market
- Aurora Cannabis Announces Date of Annual General Meeting
- Village Farms International Announces Pure Sunfarms’ Receipt of Health Canada Approval Enabling It to Commence Cannabis Extraction Operations
- Delta 9 Achieves Milestone in Agreement with Micro Cultivation Partner
- MediPharm Labs Secures 100% Ownership of its Australia Subsidiary, Poised for New Wave of Global Medicinal Cannabis Growth
- Tilray Medical Cannabis Product Shows Promise Reducing Nausea and Vomiting Caused by Chemotherapy in World First Clinical Trial
All posts made on this website are provided for information purposes only. None of the information here is intended as investment advice, as an offer or solicitation of an offer to buy or sell, or as a recommendation, endorsement, or sponsorship of any security, Company, or fund. Before making an investment decision, you should seek the advice of a qualified and registered securities professional. Candlr is not receiving payment or commissions from companies for shared content on Candlr website unless its specified. View full disclaimer HERE.